The QualityStocks Daily Thursday, March 24th, 2022

Today's Top 3 Investment Newsletters

Stocks to Buy Now(MCOA) $0.0013 +78.57%

QualityStocks(NNRX) $0.0004 +60.00%

BioMedWire(INM) $1.0500 +39.07%

The QualityStocks Daily Stock List

Medical Marijuana (MJNA)

SmallCapVoice, PennyStocks24, CFN Media Group, InvestorPlace, The Green Baron, Profitable Trader Authority, OTCtipReporter, PennyStockScholar, SmallCapStockPlays, Greenbackers, Promotion Stock Secrets, OTC Stock Review, marketwirepress, Bull in Advantage, AllPennyStocks, Jason Bond, RockingPennyStocks, Money Morning, Penny Stock Rumble, QualityStocks, Buzz Stocks, SmallCapReview, Planet Penny Stocks, Stockpalooza, Real Pennies, Penny Stocks VIP, OTCJournal, smartOTC, StockEgg, Wealth Insider Alert, HotOTC, BullRally, Stock Rich, PennyStockProphet, Stock Analyzer, FeedBlitz, Pennybuster, Cannabis Financial Network News, CoolPennyStocks, MicroCapINPLAY, Darth Trader, Market Intelligence Center Alert, TheStockWizards.net, FatCat Stocks, Market Authority, Jet-Life Penny Stocks, StockOnion, OTCPicks, SmallCap Network, StockHideout, Stockgoodies, PenniesPicks, Stock Stars, HotShotStocks, The Stock Psycho, Orbit Stocks, Apex Pennystocks, All about trends, BestOtc, Energy & Resources Digest, Flagler Financial Group, Hot Stock Profits, Insider Wealth Alert, MajorPennyStocks, TopStockAnalysts, PennyStockSpy, Stocks That Move, StockSituationRoom, The Online Investor, The Street, Top Pros' Top Picks, StockMister, TopPennyStockMovers, Stock Source, VIP Penny Stocks, Wall Street Corner, Wall Street Resources, Wallstreet Profiler, WallstreetSurfers, Wealth Daily and WeeklyPennyPick reported earlier on Medical Marijuana (MJNA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medical Marijuana, Inc. (OTC: MJNA) is an investment and holding firm that is engaged in the development, distribution and sale of hemp oil which has naturally occurring cannabinoids which include CBD and other products that contain hemp-oil that’s rich in CBD, non-psychoactive cannabidiol products and cannabinoid medical products/chewing gum-based cannabis, which is used to treat pain and other medical disorders.

The company has its headquarters in San Diego, California and was founded in 2005. It distributes its products to consumers across the globe and operates through 3 segments. They include: Kannway, HempMeds and U.S. Operations. The company’s brands include Canchew, Kannakik, Hempvap, Revive and Defined while its services include the development of medical grade compounds and the development of CBD based wellness and health products.

The firm provides environmentally-friendly supplies; non-GMO plant-based pet products for health and wellness, play and wear as well as RSHO oil for the treatment of different conditions and ailments. In addition to this, the firm is also engaged in the research and development of novel therapeutic agents that have been developed to act as neuroprotectants and immune-modulators which reduce oxidative stress. It also develops prescription-based hemp oil, skin care products, dietary supplements under the HempMeds and Kannaway brands; labeling, packaging, tracking, standardization and production methods for the medical CBD industry.

With the U.S. medical marijuana market set to grow exponentially in the near future as more and more states legalize the herb, the company is set to profit heavily as the demand for marijuana and marijuana products increases.

Medical Marijuana (MJNA), closed Thursday’s trading session at $0.0219, up 37.7358%, on 40,884,784 volume. The average volume for the last 3 months is 35.801M and the stock's 52-week low/high is $0.0001/$0.07.

cbdMD Inc. (YCBD)

Schaeffer's, InvestorPlace, MarketBeat, StockMarketWatch, QualityStocks, The Street, CFN Media Group, Wealth Insider Alert, Top Pros' Top Picks, StreetInsider, Red Chip, Money Morning and MarketClub Analysis reported earlier on cbdMD Inc. (YCBD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

cbdMD Inc. (NYSE American: YCBD) is a pharmaceutical firm that is engaged in the production and distribution of cannabidiol (CBD) products.

The firm has its headquarters in Charlotte, North Carolina and was incorporated in 2015, on March 17th by Caryn Dunayer. Prior to its name change in May 2019, the firm was known as Level Brands Inc. It operates as part of the pharmaceutical and medicine manufacturing industry, in the health care sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company operates and owns consumer hemp-based CBD brands like Paw CBD and cbdMD. It distributes its products through different brick and mortar retailers across the United States, as well as through wholesalers, 3rd party e-commerce sites and its e-commerce website.

The enterprise’s product categories include animal treats and oils, CBD-infused topical creams, CBD-infused bath bombs, CBD gummies, capsules and CBD tinctures. It provides veterinarian-formulated products like topicals, chews and tinctures under its Paw CBD brand. Under its cbdMD brand, it offers CBD sleep aids, CBD vape oils, CBD bath salts, bath bombs, CBD oil capsules, CBD topicals, CBD gummies and tinctures. All the enterprise’s products are THC-free and have undergone 3rd party testing to ensure their safety.

The company recently entered into an agreement with IM Cannabis Corp., which will facilitate the brand’s entrance into the Israeli market. In addition to bringing in more revenue, this move will help extend the company’s consumer reach and boost investments into the company.

cbdMD Inc. (YCBD), closed Thursday’s trading session at $1.09, up 31.3253%, on 888,330 volume. The average volume for the last 3 months is 770,446 and the stock's 52-week low/high is $0.703301/$4.22.

Ampio Pharmaceuticals (AMPE)

Profitable Trader Authority, StockMarketWatch, Ceocast News, BUYINS.NET, StreetInsider, MarketClub Analysis, Dynamic Wealth Report, The Street, MarketBeat, Hit and Run Candle Sticks, Rick Saddler, OTCtipReporter, Street Insider, PennyStockScholar, BestOtc, CRWEWallStreet, CRWEPicks, CRWEFinance, DrStockPick, Real Pennies, TradersPro, PennyToBuck, PennyTrader Publisher, QualityStocks, PennyOmega, StockHotTips, TraderPower, CoolPennyStocks, The Online Investor, Stocks That Move, SmarTrend Newsletters, PennyStockCrowd, Greenbackers, INO.com Market Report, MissionIR, Penny Stock Rumble, Wealthpire Inc. and Schaeffer's reported earlier on Ampio Pharmaceuticals (AMPE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ampio Pharmaceuticals Inc. (NYSE American: AMPE) (FRA: APH) is a biopharmaceutical firm that is engaged in developing new immunology-based therapies for treating common inflammatory conditions for which there are limited treatment options.

The firm has built a robust portfolio of issued patents and pending patent applications on its products. It also has strong relationships with specialized product and service providers, regional hospitals, academic medical centers and clinicians, which is central to its successful clinical development programs. It has sponsored clinical, basic and translational research projects which are aimed at particular disease mechanisms. The firm has its headquarters in Englewood, California and was incorporated in April 2020 by David Bar-Or. It serves consumers in the United States.

The enterprise’s product pipeline is made up of new molecular entities and new uses for already approved drugs developed for important therapeutic areas which include central nervous system ailments, sexual dysfunction, inflammation, kidney disease, eye disease and metabolic diseases. Its products include an intra-articular injection treatment dubbed Ampion, which contains small molecules and cyclized peptides derived from blood which targets various pathways affected by inflammatory ailments. The formulation is indicated for the treatment of severe osteoarthritis of the knee, as well as an inhaled treatment for coronavirus-induced respiratory distress and an IV treatment for the coronavirus disease. The enterprise is currently advancing the formulation’s clinical trials in the U.S.

The company’s Ampion candidate is being considered for emergency use authorization in the treatment of the coronavirus disease. Its approval would not only bring in more investors into the company but also benefit patients with this indication.

Ampio Pharmaceuticals (AMPE), closed Thursday’s trading session at $0.556, up 29.5132%, on 33,465,957 volume. The average volume for the last 3 months is 32.961M and the stock's 52-week low/high is $0.3905/$2.005.

Aptevo Therapeutics (APVO)

StockMarketWatch, MarketBeat, TraderPower, StreetInsider, MarketClub Analysis, TradersPro, QualityStocks, Stock Beast, Promotion Stock Secrets, Marketbeat.com and BUYINS.NET reported earlier on Aptevo Therapeutics (APVO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aptevo Therapeutics Inc. (NASDAQ: APVO) (OTC: APVTW) (FRA: AP8N) is a clinical-stage biotechnology firm that is engaged in the development of immunotherapeutic candidates for treating different forms of cancer.

The firm has its headquarters in Seattle, Washington and was incorporated in 2016, on February 22nd. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers in the United States.

The company offers hematology and oncology therapeutics. It is party to an option and collaboration agreement with Alligator Biosciences AB, which entails the development of its ALG. APV-527 formulation.

The enterprise’s product pipeline comprises of a dual agonist bispecific antibody dubbed APVO603 which targets OX40 and CD137; and an investigational bispecific APAPTIR candidate known as ALG.APV-527 which features a mechanism of action which targets CD137 and a tumor antigen expressed in different types of cancers known as 5T4. It also develops a bispecific candidate known as APVO442, which improves the bio-distribution of drugs to PSMA positive tumors for treating prostate cancer. In addition to this, the enterprise also develops a bispecific T-cell engaging antibody candidate dubbed APVO436, which is undergoing a phase 1 clinical trial evaluating its effectiveness in treating myelodysplastic syndrome and acute myelogenous leukemia.

The firm seeks to improve the treatment outcomes of cancer patients. Currently, it is focused on receiving data from its APVO436 phase 1b expansion trial, which has the potential to impact the existing standard of care for acute myeloid leukemia.

Aptevo Therapeutics (APVO), closed Thursday’s trading session at $6.96, up 32.8244%, on 6,730,197 volume. The average volume for the last 3 months is 6.589M and the stock's 52-week low/high is $4.40/$31.76.

Nutranomics Inc. (NNRX)

QualityStocks, PennyStocks24, Pumps and Dumps, PennyStocks Forever, PennyOmega, PennyToBuck, Real Pennies, StockHotTips, Stock Stars, BestOtc, MicrocapAlliance, Global Equity Alert, DrStockPick, CRWEWallStreet, CRWEPicks, CRWEFinance and MonsterStocksPicks reported earlier on Nutranomics Inc. (NNRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nutranomics Inc. (OTC: NNRX) is focused on researching, developing and selling nutritional food products.

The firm has its headquarters in Salt Lake City, Utah and was incorporated in 1995 by Tracy K. Gibbs. The firm serves consumers around the globe.

The company is party to a strategic partnership agreement with Terra-Formance LLC. Its aim is to expand its intellectual property to include a pre-digestive delivery system poised to revolutionize the way individuals ingest supplements.

The enterprise provides about 480 nutritional supplements, which include probiotic supplements, herbal supplements, mineral supplements and formulating vitamin supplements. These nutritional products include Mobility and Flexibility Complex, Pre Pro-Biotic, PhytoNutrient, Immune Modulating Complex, South American Herbal Blend, Glucozyme, All Natural Vitamin C Complex, The Works, Total Body Detox and Viral Guard. It also offers the Assimilation Enhancing System, a patented system which improves the absorption of nutrients in the body; and a tool that examines a consumer’s blood cells in real time, live, on a video monitor dubbed Nutritional Blood Analysis. In addition to this, the enterprise provides educational services, which include different types of trainings, certifications, analysis and group presentations to industry professionals and individuals. It distributes its products through retail stores, as well as through sales representatives throughout Asia and North America.

The firm plans to acquire DHS Development Inc., which will focus on the production of its core products like tablets, capsules and gummies, among others. In addition to producing top quality products for its consumers, this move will allow the firm to improve its production facility, which will have a positive effect on its efficiency and product quality.

Nutranomics Inc. (NNRX), closed Thursday’s trading session at $0.0004, up 60%, on 312,797,573 volume. The average volume for the last 3 months is 312.798M and the stock's 52-week low/high is $0.000195/$0.0033.

MedMen Enterprises, Inc. (MMNFF)

InvestorPlace, QualityStocks, MarketBeat, MarketClub Analysis, Profit Trends, CFN Media Group, Top Pros' Top Picks, Trading For Keeps, The Online Investor, SmallCapVoice, Wealth Insider Alert, The Street, Trades Of The Day, Investment U, Daily Trade Alert, Daily Profit and Profit Confidential reported earlier on MedMen Enterprises, Inc. (MMNFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MedMen Enterprises, Inc. brings expertise and capital to the cannabis industry. The Company is one of the nation’s largest financial supporters of progressive marijuana laws. MedMen Enterprises owns and operates facilities covering the whole vertical from cultivation to manufacturing to retail in key states, including California, Nevada, and New York. MedMen Enterprises is headquartered in Culver City, California and the Company lists on the OTC Markets Group’s OTCQX.

MedMen Enterprises manages class leading retail stores that sell marijuana and marijuana products. The Company operates a number of dispensaries in the most strategic markets in the nation. It has a fast-growing footprint that includes expansion plans in other important States and also Canada. At present, MedMen has flagship stores in Los Angeles, Las Vegas and New York.

The Company has added ground cannabis flower to its product offerings in the State of New York. At present, its stores in New York offer vaporizer pens, tinctures and gel caps in five different formulations. The addition of ground flower will give its New York medical marijuana patients more product choices in the State’s fast developing marketplace.

MedMen Enterprises earlier announced its expansion into Florida via a proposed acquisition of dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates. MedMen secured prime retail locations with long term leases in Ft. Lauderdale, Miami Beach, West Palm Beach, St. Petersburg and Key West. MedMen Enterprises also acquired a dispensary and cultivation license and related assets from Florida based Treadwell Simpson Partnership and affiliates (Treadwell Nursery).

The company recently announced its Cannasseur Personal Concierge Service, a personal shopping program now available in California, Nevada, Arizona and Florida dispensaries. Led by MedMen’s top in-store cannabis experts, or ‘Cannaseurs’, the service offers customers free one-on-one consultations with seasoned budtenders, covering everything from individualized product and strain recommendations to cannabis education and responsible use.

MedMen Enterprises, Inc. (MMNFF), closed Thursday’s trading session at $0.1636, up 41.0345%, on 7,016,553 volume. The average volume for the last 3 months is 7.015M and the stock's 52-week low/high is $0.0932/$0.44.

Yumanity Therapeutics (YMTX)

MarketBeat reported earlier on Yumanity Therapeutics (YMTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Yumanity Therapeutics Inc. (NASDAQ: YMTX) (FRA: 8IY) is a clinical-stage biopharmaceutical firm that is focused on studying and developing treatments for neurodegenerative illnesses caused by protein misfolding.

The firm has its headquarters in Boston, Massachusetts and was incorporated in December 2014 by Tony Coles and Susan Lindquist. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company is focused on accelerating revolution in the treatment of neurodegenerative ailments, via its transformative drug discovery platform and scientific foundation. Its platform allows for the rapid screening for new disease modifying medications and illness targets that can overcome toxicity in illness-causing gene networks. The company is party to a strategic research and development collaboration agreement with Merck Sharp &Dohme Corporation.

The enterprise develops illness-modifying therapies to treat Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, multiple system atrophy, dementia with Lewy bodies and Parkinson’s disease. Its product pipeline comprises of a new small molecule drug dubbed YTX-7739, for the treatment of Parkinson’s disease. The formulation also treats associated disorders of a-synuclein that is in phase 1 trials. The enterprise also develops a formulation known as YTX-9184, to treat dementia with Lewy bodies.

The firm’s board of directors recently announced restructuring plans to help preserve firm capital. In addition to this, the firm is currently exploring strategic alternatives, including mergers, acquisitions, sales of assets and other strategic transactions which will help enhance value for its shareholders.

Yumanity Therapeutics (YMTX), closed Thursday’s trading session at $2.05, up 15.8192%, on 3,161,315 volume. The average volume for the last 3 months is 3.161M and the stock's 52-week low/high is $0.95/$19.75.

Viyya Technologies (VYON)

We reported earlier on Viyya Technologies (VYON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viyya Technologies, Inc. (OTC: VYON) is focused on designing, developing, marketing and distributing personal knowledge management and business intelligence software services and tools for business customers and individual consumers in the private and public sectors.

The firm has its headquarters in West Caldwell, New Jersey and was incorporated by John Bay. Prior to its name change in September 2004, the firm was known as Viyon Technologies Inc. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe.

The enterprise’s objective is to create a multi-functional software platform that is effective with every version and vertical market application which performs a number of IT functions, including identifying and managing disparate types of data and information, and content aggregation. It markets information management applications that manage information from the internet and other sources. Its core technology solution, dubbed Viyya, is a business intelligence application which has been designed to manage day-to-day information needs. This technology enables users to customize the way they gather, process and distribute data from blogs, RSS feeds, the Intranet and the Internet. The enterprise’s technology solution also allows users to retrieve filtered data from various sources, organize the data using multiple options and deliver the data to a range of devices. This is in addition to being applied in cryptocurrency management and mining.

The company is mainly focused on enhancing shareholder value by taking advantage of upcoming opportunities in its markets, which may help bring in more investors and extend its product reach.

Viyya Technologies (VYON), closed Thursday’s trading session at $0.0016, off by 42.8571%, on 1,125,000 volume. The average volume for the last 3 months is 1.125M and the stock's 52-week low/high is $0.0002/$0.0154.

Vallon Pharmaceuticals (VLON)

MarketClub Analysis, TradersPro and BUYINS.NET reported earlier on Vallon Pharmaceuticals (VLON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vallon Pharmaceuticals Inc. (NASDAQ: VLON) is a biopharmaceutical firm that is focused on developing and commercializing new abuse-deterrent drugs for disorders of the central nervous system.

The firm has its headquarters in Philadelphia, Pennsylvania and was incorporated in 2018, on January 11th by David C. Baker. It operates as part of the pharmaceutical and medicine manufacturing industry, under the health care sector. The firm serves consumers in the United States.

The enterprise’s product pipeline includes an abuse-deterrent oral formulation of immediate-release dextroamphetamine, ADAIR, which has been designed to treat narcolepsy and ADHD (attention-deficit/hyperactivity disorder). Narcolepsy is a chronic sleep disorder which is characterized by sudden attacks of sleep and overwhelming daytime drowsiness. ADAIR has been designed to offer barriers to injection and put off attempts to crush and snort. This formulation will be streamlined through an FDA regulatory pathway and will be the 1st abuse-deterrent dextroamphetamine formulation. It also develops an abuse deterrent methylphenidate formulation known as ADMIR, for the treatment of ADHD. ADHD is a common neurodevelopmental medical condition which mainly affects children. Individuals suffering from this disorder may be overly active or have trouble controlling impulsive behaviors and paying attention.

The company remains focused on developing new therapies that help address the unmet needs of patients suffering from central nervous system disorders. The success and approval of its formulations will not only help patients with these indications but also bring in additional revenue and investors into the company, which will positively influence its growth.

Vallon Pharmaceuticals (VLON), closed Thursday’s trading session at $2.16, up 1.8868%, on 721,933 volume. The average volume for the last 3 months is 697,547 and the stock's 52-week low/high is $2.08/$10.36.

Cenntro Electric Group (CENN)

We reported earlier on Cenntro Electric Group (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cenntro Electric Group Ltd (NASDAQ: CENN) (FRA: 0SQ) is a commercial electric car technology firm that is focused on manufacturing electric medium-duty and light commercial vehicles.

The firm has its headquarters in Freehold, New Jersey and was incorporated in 2017, on May 11th. Prior to its name change, the firm was known as Naked Brand Group Ltd. It operates as part of the auto manufacturers industry, under the consumer cyclical sector. The firm serves consumers across the globe, with a primary focus on those in the United States and Australia.

The company’s business model enables it to design, manufacture, assemble and sell electric vehicles to third parties for distribution and services to end-users. Its objective is to lead transformation in the automotive industry via decentralized and scalable production and the development of fully digitalized autonomous driving solutions.

The enterprise’s electric vehicles have been designed to serve various governmental and corporate organizations in support of last-mile delivery services, city services and other commercial applications. These electric vehicle models include the ORV, Neibor 200, Logistar 400 and the Metro. It also distributes already manufactured car kits which are usually assembled, homologated, serviced and sold by 3rd parties in different markets. The enterprise has also developed an in-house telematics box which enables its electric vehicles to receive and send data concerning acceleration, speed, location, battery consumption and braking.

The firm recently entered into an agreement to acquire majority interest in Tropos Motors Europe. This move will speed up the firm’s expansion into Europe, Africa and the Middle East, increase its revenues and bring it closer to becoming a major provider of electric commercial mobility.

Cenntro Electric Group (CENN), closed Thursday’s trading session at $2.61, off by 1.8797%, on 22,503,705 volume. The average volume for the last 3 months is 22.504M and the stock's 52-week low/high is $1.05/$15.00.

Alvopetro Energy (ALVOF)

Wall Street Mover, PoliticsAndMyPortfolio and Real Pennies reported earlier on Alvopetro Energy (ALVOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alvopetro Energy Ltd (OTCQX: ALVOF) (CVE: ALV) is an exploration firm that is focused on acquiring, exploring for, developing and producing hydrocarbons.

The firm has its headquarters in Calgary, Canada and was incorporated in 2013, on September 25th. It operates as part of the oil and gas E&P, under the energy sector. The firm serves consumers across the globe.

The company’s objective is to become a major independent midstream and upstream operator in Brazil. It operates through its subsidiary, which is involved in providing custom acid blending services for production optimization fluids and fracture stimulation. It generates the majority of its revenues from the sales of its exploration business. The company has operations in various parts of Canada.

The enterprise operates onshore oil and gas fields and hydrocarbons. Its natural gas projects include Gomo and Caburé. It is focused on exploring onshore natural gas potential, in Bahia state, Brazil, building off the construction of infrastructure assets and the development of its Gomo and Cabure natural gas projects. It produces hydrocarbons from the Reconcavo basin, which is located on-shore Brazil. The enterprise also owns a pair of oil fields, including Bom Lugar and two more exploration assets, which make up about 23,530 acres.

The firm is focused on developing and expanding its reserve base as well as its production of natural gas, which will positively impact revenues into the firm. It also plans to maximize the use of its strategic midstream infrastructure and unlock the natural gas potential in some states in Brazil, which may be good for its investments and growth.

Alvopetro Energy (ALVOF), closed Thursday’s trading session at $4.3501, off by 0.908884%, on 12,338 volume. The average volume for the last 3 months is 12,338 and the stock's 52-week low/high is $1.36/$8.00.

Statera Biopharma Inc. (STAB)

We reported earlier on Statera Biopharma Inc. (STAB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Statera Biopharma (NASDAQ: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced the pricing of its underwritten public offering. The offering is comprised of an estimated 10,843,721 units, offered to the public at $0.45 per unit, and approximately 1,716,666 prefunded units offered for $0.44 per unit. The company anticipates gross proceeds of approximately $5.7 million before expenses.

Each unit includes one share of common stock, one warrant with a one-year term to purchase one share of common stock and one warrant with a five-year term to purchase one share of common stock; the shares of common stock, the one-year warrants and the five-year warrants are issued separately and uncertificated. The announcement also noted that STAB has granted the underwriters a 45-day option to purchase up to an additional 1,884,057 shares. The offering is expected to close on or about March 24, 2022.

To view the full press release, visit https://ibn.fm/oYIaP

About Statera Biopharma Inc.

Statera Biopharma (formerly Cytocom) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. Statera Biopharma has a large platform of toll-like receptor (“TLR”) agonists with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532. TLRs are a class of protein that plays a key role in the innate immune system. Statera Biopharma is developing therapies designed to directly elicit within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases and cancers. Statera Biopharma has clinical programs for Crohn’s disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401) and COVID-19 (STAT-205) in addition to potential expansion into fibromyalgia and multiple sclerosis. To learn more about the company, visit www.StateraBiopharma.com.

Statera Biopharma Inc. (STAB), closed Thursday’s trading session at $0.3451, up 0.906433%, on 6,891,532 volume. The average volume for the last 3 months is 6.892M and the stock's 52-week low/high is $0.319998/$7.17.

The QualityStocks Company Corner

Sanwire Corp. (SNWR)

The QualityStocks Daily Newsletter would like to spotlight Sanwire Corp. (SNWR).

Sanwire’s (OTC: SNWR) wholly owned subsidiary, Intercept Music, a software-as-a-service (“SaaS”) entertainment technology company, today announced a turnkey solution of its service suite designed for celebrities who want to create their own music label. Now, from a single source, Intercept Music, anyone looking to extend their brand into the independent music market can instantly acquire world-class label capabilities. The emergence of celebrity-backed labels is one of the strongest trends in independent music, and Intercept Music's concierge-level service and breadth of offerings for independent artists make an ideal platform for those who want a streamlined, seamless path to building a label of their own. “One of the great aspects of bringing a product and service to market is to see the innovative ways that our customers are using it,” Tod Turner, CEO of Intercept Music, said in the press release. “Our suite of services were tailor-made for existing independent labels. New labels, like IronGate Records in Nashville, have started from scratch with our software platform, and building on their relationships, have quickly achieved success. They'll be at 200 artists by year-end.” To view the full press release, visit https://ibn.fm/EOTFr

Sanwire Corp. (SNWR) is a diversified company currently focused on technologies for the music industry. The company specializes in locating unique opportunities in fragmented markets and implementing its aggregated technologies to consolidate distinct services into unified platforms of delivery. Sanwire is currently focusing these efforts on advanced entertainment technologies.

Founded in 1997 and based out of Las Vegas, Nevada, Sanwire has operated and sold several subsidiaries as it has worked in various industry segments, including Sanwire Software Inc., Bullmoose Mines Ltd. and Squeeze Report Inc. Currently, there are two new holdings that were added to the company’s portfolio through two recent acquisitions, including Intercept Music Inc. in March 2020 and the Art is War Record Label in June 2020.

Intercept Music Inc. – Artist-Focused Services

Intercept Music Inc. is an entertainment technology company offering a unique suite of artist-focused services that are specifically designed to meet the needs of recording artists. Intercept’s proprietary online platform is dedicated to helping millions of global independent artists effectively promote their music and distribute it worldwide to hundreds of digital stores and every major streaming platform, including Spotify, Apple Music, Amazon Music, Pandora and Google Music.

With Intercept Music, recording artists have all the tools needed to market, promote and sell their music online and through social media. Comprehensive reporting allows artists to track the fan response to their releases, all the way down to individual music tracks.

There are three foundations of Intercept Music’s product offering:

  • Its music distribution platform that is well augmented via the company’s partnership with InGrooves, a wholly owned subsidiary of Universal Music, which is arguably one of the largest music companies in the world.
  • Its social media system, which is tailored to work the way artists use social media to promote their music and engage with their fans. The scheduling system integrates artists’ profiles across multiple social networking sites (Facebook, Twitter, Instagram and YouTube) to facilitate new audience sampling, fan development and the ability for music to be previewed and purchased.
  • The third is represented by the team of developers that brings a unique combination of deep technical expertise (in products like Skype), a team of well-accomplished executives and what the company calls Brand Ambassadors – senior reps from multiple genres who have helped artists earn over 100 Grammys.

Intercept Music is the confluence of technology and this music expertise.

The company currently markets three plans to its clients, with each offering different distribution and royalty options, as well as various marketing and reporting options. The plans are described below:

  • Intercept Distro is a basic plan for self-service music distribution with royalty collection. Artists keep 100% of the royalties while receiving unlimited releases and full analytics with reporting.
  • Intercept Artist includes all of the benefits of the basic Distro plan with added emphasis on social marketing and distribution for emerging artists. With this plan, artists receive scheduled and ad-hoc posting, social media reporting, reusable content libraries and access to other valuable features.
  • Intercept PLUS is available by invite only and is for established artists looking for a complete suite of marketing, distribution and monetization services. The PLUS plan includes everything available through the Distro and Artist plans, as well as offering a dedicated service representative, a branded online store, on-demand merchandise, additional marketing, YouTube monetization and other pro features.

Intercept PLUS is the flagship plan. Artists of this caliber often do $3-$10k/month in merchandise sales alone, at 50%+ profit. Intercept is responsible for marketing to the fan base through its social media system and shares in the profits generated. The stores are managed by intercept so both top-line revenues and bottom-line profits flow through Intercept.

Intercept Music has partnered with Ingrooves Music Group, the largest online music distribution company in the world, for worldwide distribution to streaming services and leading stores. Completing more than 50 billion transactions weekly across over 150 countries, Ingrooves supplies music to leading streaming music platforms and lists some of the world’s largest and most reputable music labels among its clients. The partnership allows Intercept Music and its clients to reach a much wider audience and start earning revenue as soon as possible by leveraging Ingrooves’ quality control systems and direct relationships with leading music streaming services.

Physical Distribution Options for Intercept Music Clients

In a press release on June 25, 2020, Intercept Music announced that it would be offering artists physical distribution through major retailers such as Amazon, FYE and Walmart (http://nnw.fm/NSrbE). The physical distribution will consist of CDs and vinyl and will serve as a supplement to the online streaming platform access provided by the company to represented artists.

“In the current climate, artists can’t play shows or otherwise engage in public at all, so they’re focusing on all other opportunities to bring in revenue,” Intercept Music President Tod Turner stated in a news release. “Our only priority is to help artists monetize music in every way, and with physical distribution added to the mix, we’re leaving no stone unturned in helping artists to earn money from their creative output.”

Creation of Preferred Stock

On June 29, 2020, Sanwire CEO Christopher Whitcomb announced that the company would be filing certificates of designation with the Nevada Secretary of State for its Series A, B and C preferred stock (http://nnw.fm/svrQt).

Speaking about this designation in a news release, Whitcomb stated, “Our paramount goal is to maintain a balanced approach between future investments and shareholder value while minimizing shareholder dilution. The effective utilization of preferred stock ensures our company can grow with the least amount of shareholder dilution.”

Sanwire is leveraging a multi-dimensional strategy that includes additional acquisitions, attracting investors and enhancing the current balance sheet while minimizing dilution for shareholders. A primary goal of these efforts is to support Intercept’s ongoing operations.

Financial Highlights

For the fiscal quarter ended June 30, 2020, Sanwire announced significant revenue growth related to the acquisitions of Intercept Music and Art is War Records. Since acquiring Intercept Music in March and Art is War Records in June, Sanwire’s revenue has increased by approximately 300% (http://nnw.fm/j0S0j). Sanwire attributes the increase in revenue to Intercept Music’s customer acquisition and the release of its PLUS plan.

For the third quarter, revenue is expected to continue an upward climb, owing largely to physical distribution plans and a rising number of PLUS subscribers. The company’s acquisition of Art is War Records is also expected to fuel this growth.

Management

Christopher M. Whitcomb is the current CEO of Sanwire Corp. and Intercept Music Inc. He is a CPA in the state of California, holding bachelor’s degrees in accounting, corporate finance and business management with a focus on real estate. A seasoned executive, his business ventures are always strongly focused on the development and financing of companies.

Whitcomb worked alongside Ralph Tashjian at SMC Entertainment Inc. and Digital Music Universe. They are currently working together again following Sanwire’s acquisition of Intercept Music, which was founded by Tashjian.

Sanwire Corp. (SNWR), closed Thursday’s trading session at $0.0095, up 6.7416%, on 35,001 volume. The average volume for the last 3 months is 35,001 and the stock's 52-week low/high is $0.005/$0.028.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

  • FuelPositive Corp. is a clean energy solutions innovator focused on delivering accessible and affordable alternatives to planet-polluting fuel systems and ammonia production systems, particularly in the ever-important agricultural sector
  • The war in Ukraine has heightened global food security concerns already raised by the COVID-19 pandemic and ongoing planetary climate change, given the amount of food, fertilizer and fuel annually sourced from Ukraine and Russia
  • FuelPositive’s IP promotes local generation of green, nitrogen- and hydrogen-rich ammonia for earth-friendly energy and agricultural needs
  • FuelPositive plans to begin rolling out prototypes of its intellectual property this summer — a portable, modular, environmentally safe system for producing ammonia on site, as well as hydrogen as a byproduct

The war in Ukraine is accelerating international food supply and climate change concerns, and indirectly demonstrating the importance of efforts by companies such as clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) to establish a more locally reliant, green supply chain for energy resources, food production and sustainable energy storage systems.

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Thursday’s trading session at $0.118, off by 1.2552%, on 30,906 volume. The average volume for the last 3 months is 30,906 and the stock's 52-week low/high is $0.09/$0.326.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

  • The Lightning Network provides instant payment transfers/settlement times, scalability, low costs/fees, and works across blockchain with the same cryptographic hash function
  • The Network’s capacity grew from 1,089 BTC to 3,479 BTC in 12 months
  • LQwD’s active public nodes on the Lightning Network include France, England, Singapore, Sweden, Italy, Indonesia, Germany, Ireland, and the U.S. and collectively have a value of 10.21604901 BTC (US$429,153.33) and 183 active channels

In early October 2021, the research division for Arcane Crypto released their predictions on the advancement of the Lightning Network — hypothesizing that by 2030, the number of users could cross the threshold of 700 million worldwide (https://ccw.fm/Tkb7R). The foundation of their research is the consistent growth of the network since 2020, with a wallet payment volume that increased by approximately 20% month-over-month during 2021. They also believe that remittance, gaming and streaming use cases will help realize these numbers in the future. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company invested in the adoption of Bitcoin and associated technology, introduced its platform-as-a-service (“PaaS”) in November 2021, offering users the ability to make payments instantly, securely and inexpensively, while leveraging the Lightning Network. Since that time, LQwD has also invested in the Lightning Network, with nine active public nodes on the network. The active nodes include France, England, Singapore, Sweden, Italy, Indonesia, Germany, Ireland, and the U.S. Collectively, the public nodes have a value of 10.21604901 BTC ($429,153.33) and 183 active channels.

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Thursday’s trading session at $0.1954, up 3.4136%, on 4,400 volume. The average volume for the last 3 months is 4,400 and the stock's 52-week low/high is $0.133/$4.00.

Recent News

Nowigence Inc.

The QualityStocks Daily Newsletter would like to spotlight Nowigence Inc.

  • An all-in-one, easy-to-use personal knowledge management platform, Pluaris assists users with automated reading and analysis of textual data.

The sheer volume of information available in the digital realm is unfathomable. Despite these astronomical numbers, many people want to — or are expected to — be on top of the latest and greatest information. A recent “Seed Scientific” report included words such as zettabytes, exabytes and petabytes when talking about data on the internet (https://ibn.fm/ecmNR). While these words may sound almost made up, they are real measurements in today’s data-driven world, measurements that Nowigence is keenly aware of.

Nowigence Inc. is a fast-growing SaaS (Software-as-a-Service) company that develops and sells a ready-to-use artificial intelligence (AI) platform called Pluaris™ that automates reading and analysis of textual data. Individuals, teams, and enterprises can now quickly distill knowledge buried in narrative-intensive documents instantaneously from various data sources, both public and private.

Pluaris is created for those who want to read more in less time. It is a Personal Knowledge Management (PKM) tool that generates an annotated data feed based on your topics of interest and automatically creates a permanent personal knowledge base from your feed and private uploads. It has human-like capabilities for comprehending textual data. It summarizes, provides precise answers to questions asked, analyzes different data perspectives, discovers new connections, creates organized nested notes, and allows teams to work collaboratively by sharing in real-time from anywhere in the world to draw informed conclusions.

By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Nowigence puts the power of data science in the hands of consumers. It helps individuals, teams, and organizations to quickly build expertise on one or multiple topics by generating a trove of critical information.

Nowigence targets two user types that rely heavily on fast and accurate research as primary adopters of the Pluaris platform. The first is knowledge workers of all kinds – anyone whose job is to “think for a living” like marketing professionals, researchers, legal professionals, academics, journalists, editors, scientists, and other professionals. The second are individual users who are life-long learners, hobbyists, and enthusiasts of all stripes.

Rather than spending time reading information to gain knowledge from one source at a time, users of Pluaris can gain knowledge from hundreds or thousands of sources in seconds. Keyword-based search-and-retrieval applications don’t open documents, nor read their content, nor extract key points, conduct cause and effect analysis or answer questions specifically. Pluaris includes all those features and goes one step further, with its semantic capabilities to empower users with interpretations of retrieved information. Nowigence estimates this feature alone can save typical researchers between one and three hours per workday. The platform also reduces “noise” by extracting only important and relevant information on every topic being monitored or researched. This helps cut down on information overload, a major source of workplace stress.

Pluaris Builds Intelligence

The Problem

In the modern world, virtually everyone needs to consume a tremendous amount of text-based information, in both our personal and professional lives, but doing so is exceptionally challenging because of:

  • Information Overload: For virtually any significant topic of interest, the amount of textual information available and continually generated is vastly more than can be consumed by an individual.
  • Pervasive Distractions: Thanks to modern technology, we are constantly bombarded with new inputs (e-mails, instant messages, social media, and more) reducing our attention span, leading all too often to TL;DR (Too Long, Didn’t Read).
  • Highly Imperfect Human Recall: The information that we do find time to read is easily forgotten. Even if we retain some of the key insights, the details are almost certainly lost.

Even when working in teams, we often end up researching the same content as our colleagues, and too much of the information acquired by one individual is lost in translation with the communication process to others.

Pluaris

Nowigence has worked with stalwarts and pioneers in the fields of Machine Learning (ML) and Natural Language Processing (NLP) from its early days. The company was keen to solve the big problem of the information age – too much data exists and cannot be processed manually.

Pluaris is designed to be used by regular people from day one with no need for extensive training. The platform is used across different functions and sectors, adapting to clients’ ever-changing needs. Its state-of-the-art no code editing gives organizations the flexibility to improve and tailor their results without hiring data scientists, and real time information retrieval ensures the client never misses any piece of intelligence.

Pluaris adapts to the unique needs by which individuals absorb knowledge. It doesn’t impose structured or rigid methodology. Real time operation means that Pluaris will deliver outputs instantaneously with a click.

A Nowigence team of experts spent three years training Pluaris to understand the context of every sentence it reads. If Pluaris does make an error in contextual interpretation, the user can correct it, which will instantly give the correction precedence over the ML’s algorithmic outputs. This takes away the biggest criticism against AI/ML platforms, that annotating (labeling) data and developing training datasets to build models takes too much time and effort from internal teams.

Use Cases

I need to stay on top of the latest news for my industry. Pluaris automatically retrieves and analyzes news on your topics of interest every day, so you can quickly scroll through an annotated news feed on your phone, tablet or laptop, while finishing your morning coffee.

Example: A Pluaris enterprise customer was interested in tracking news and events in the telecom industry. Nowigence was able to quickly create and then fine-tune a list of topics to monitor. In less than a week, they had an annotated news feed covering the telecom industry available to their team.

I have to come up to speed on a new topic as quickly as possible. Upload a few related websites and documents to Pluaris and within minutes you are exploring this new area of interest, scanning the summaries, gaining new insights about this topic, and finding new keywords to broaden your search and deepen your understanding.

Example: A customer who was already using Pluaris for business intelligence decided to use his account to make improvements in his health after he received a report from his doctor of a high fasting blood sugar level.

  • He uploaded a few research reports to Pluaris, read through the summaries, and explored the annotated labels. Based on that analysis, he set up Pluaris to monitor topics such as “lowering fasting blood sugar” and “low glycemic food.”
  • From those results, he built an action list of daily habits for diet and fitness and, within a couple months, brought his fasting blood sugar level back down.

I want to be able to access the information I’ve read in the past and synthesize it with my current understanding. As you continue to add more and more information to the system over time, Pluaris never forgets. You are building a knowledge base of the information that is most relevant to you.

Example: A Pluaris user at one of the world’s largest aluminum mining companies was tasked with preparing talking points for her manager for an upcoming investor meeting. Over time using Pluaris, she had built a database of documents, including transcripts, notes, Q&A sessions, speeches, annual reports, and internal documents, some of which were from previous investor meetings. She was able to quickly explore that database through the Pluaris Dashboard and using various filters. She then pulled this information together in a Pluaris Notebook and shared that note directly with her boss.

Market Outlook

Pluaris users include:

  • Knowledge WorkersGartner estimates there are more than 1 billion worldwide as of December 2019.
  • Students in Higher Education: ICEF estimates there are 250 million worldwide as of 2020. This is Nowigence’s initial target group from a market penetration perspective.
  • Personal/Home Use: Statista estimates there are 4.7 billion active internet users worldwide as of January 2021.

Nowigence offers tiered pricing, starting at $10/month/user for individuals, while team and enterprise users, who have access to more features to facilitate collaboration and integrations to other enterprise tools, start at $45/month/user.

As a result, the Total Available Market (TAM) is more than a billion users and over $1 trillion. The Market Opportunity (the Serviceable Obtainable Market or SOM) for Nowigence is $11 billion in the combined PKM and Cognitive Computing space defined by Pluaris.

This market is growing rapidly too. The Cognitive Computing market alone was valued at $8.87 billion in 2018 and is projected to reach a value of $87.39 billion by 2026, growing at a CAGR of 31.6% from 2019 to 2026, according to Allied Market Research.

Nowigence offers differentiated value compared to other Personal Knowledge Management (PKM) tools, which have reached as many as 250 million users (Evernote) and have shown rapid adoption (Roam Research reached 60,000 users and $1 million ARR within 6 weeks of launching paid plans). Unlike Pluaris, these tools do not automatically monitor public or private sources to add to your knowledge base, nor do they provide summaries or extract intelligence. Pluaris differs from search engines as well, in that search engines do not access or store personal knowledge, and they also do not summarize or extract intelligence.

Management Team

Anoop Bhatia is the founder and CEO of Nowigence Inc., where he has worked full-time since 2015. Previously, he worked as a global operation strategic transformation leader for Momentive Performance Material (formerly GE Silicones). He has worked for over two decades in various General Electric companies across different countries, including the U.S., India, The Netherlands and Germany. He played a key role in establishing GE Silicones as the first-ever wholly owned foreign subsidiary established in India in 1996. He received his Bachelor of Engineering in Chemical Engineering from BITS in India and did his post-graduate studies in management from Heriot-Watt at Edinburgh in Scotland.

Gordon Haupt is the Chief Technology Officer at Nowigence. He has more than 20 years of experience building and leading diverse engineering and operations teams, and a strong technical background in machine learning, signal processing, and statistical data analysis, including applications in speech and text, biotechnology, and computer vision. He is a named inventor on 15 issued patents and is experienced in all phases of engineering development and operations. He holds a B.S. degree in Engineering Mechanics from the University of Wisconsin and M.S. and Ph.D. degrees from Stanford University in Aeronautics and Astronautics.

David Evans is the company’s acting CFO & General Counsel. As an attorney and licensed CPA in the state of New York, he has extensive experience in multistate and international tax policies and guidelines, federal taxation laws, mergers and acquisitions, including valuation of closely held businesses. He is a contributing author to the New York State Tax Service, a six-volume publication of NYS tax laws and regulations. His prior experience includes being a Managing Director for UHY Advisors LLC, a board member and chairperson of the Tax Division Executive Committee of New York State Society of Certified Public Accountants and a past president of the Estate Planning Council of Eastern New York. He holds degrees from Hofstra University and State University of New York at Buffalo.


Recent News

chart

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was highlighted in a Wccf Tech article; Wccf (Where consumers come first) Tech is a leading global technology publication house that reports on wide-ranging topics and conducts in-depth technical and financial analysis for exclusive reports. In the article, WccF noted the continued interest that MULN is seeing from a group of Mullen FIVE EV Crossover enthusiasts. The article also pointed to rising interest among investors, citing several reasons including Mullen’s ownership of an EV manufacturing facility in Tunica, Mississippi; positive reviews of the Mullen FIVE EV Crossover; and new developments in battery technology. “Thank you to all our supporters that kept their faith in us and to everyone that sees the potential of what we have to offer,” said Mullen CEO and chair David Michery in the press release. “We are here to craft our own path in the EV market and hopefully pave the road for more innovative companies along the way.” To view the full press release, visit https://ibn.fm/M06it. A new report reveals that U.S. car dealers are not happy with the Biden administration’s direction in the auto industry. According to the Dealer Outlook Survey for 2022, dealers have aired complaints affecting the industry including the president’s plan to boost sales of electric vehicles.The survey was released by Automotive News and relied on data from 196 car dealers and dealership managers. Despite last year’s record profits, car dealers are reluctant in praising the president’s call for an EV transition. In fact they are saying that the current administration has had a negative effect on their businesses. Change is always hard when people have been used to doing things a certain way, and one wouldn’t be surprised to find that EV makers such as Mullen Automotive Inc. (NASDAQ: MULN) make their sales projections as conservative as possible to accommodate the time needed for the motoring public to adjust their minds and hearts away from the ICE vehicles they are used to.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Thursday’s trading session at $3, off by 3.537%, on 127,462,683 volume. The average volume for the last 3 months is 121.673M and the stock's 52-week low/high is $0.52/$15.90.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

Numerous studies on psychedelics have been conducted since the substances went mainstream a couple of years ago. Since then, a lot has been unearthed about the therapeutic benefits these drugs possess. Here are some important studies on psychedelics that are currently being conducted or are complete. Compass Pathways published data on its psychedelic clinical trial, which used psilocybin therapy to manage treatment-resistant depression in 2021. Trial results show that at least 36% of the participants saw a considerable reduction in their symptoms three weeks after the treatment has ended, with almost 30% of these participants improving enough to enter remission. All those studies have helped to bring psychedelics back into the mainstream, and companies such as Delic Holdings Corp. (CSE: DELC) (OTC: DELCF) can look forward to expanding their presence across the region as more psychedelic substances get approved for different medical indications.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Thursday’s trading session at $0.0825, up 10%, on 3,520 volume. The average volume for the last 3 months is 3,520 and the stock's 52-week low/high is $0.0533/$0.495.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

  • PlantX is the digital face of the plant-based community whose verticals operate across three main categories: products, distribution and community
  • The company is leveraging a robust e-commerce ecosystem to link consumers to over 5,000 plant-based products
  • By opening new locations for its XMarket brick and mortar stores, the company has strengthened its distribution capabilities
  • PlantX also offers educational resources as well as fitness solutions
  • Moving forward, the company has locked its sights on profitability, building on the growth witnessed in its most recent quarter

Created as a plant-based lifestyle brand, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has always targeted the enrichment of people’s lives through plant-based education and promoting general health, wellness and fitness, a goal that informed its adoption of a three-pronged, all-encompassing operational approach. Through its numerous verticals — whose operations are segmented into three main categories: products, distribution and community – the company has created a platform that has effectively become the one-stop shop for everything plant-based. PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) announced its strategic partnership with BESTIES Vegan Paradise (“BESTIES”), a leading company in the plant-based space that was awarded “Best Grocery Store” in the VegNews Veggie Awards for the past two years. Under the collaboration, PlantX has initiated the redesign and rebrand of its XMarket brick-and-mortar stores in Venice, California, and Hillcrest, California, under the BESTIES brand. According to the update, these locations will also include BESTIES-branded products. “It is obvious through their success with BESTIES Vegan Paradise that Matt and Asia have developed the ‘secret sauce’ in the retail space,” said PlantX Founder Sean Dollinger. “Both PlantX and I, personally, are committed to the values and ethics that Asia, Matt and the BESTIES brand have come to epitomize in the vegan community. This partnership will no doubt accelerate the already massive growth for PlantX as we confirm our commitment to those values and cement our place as a leader in the ethical vegan marketplace.” To view the full press release, visit https://ibn.fm/uv269.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Thursday’s trading session at $0.1499, off by 3.5703%, on 125,126 volume. The average volume for the last 3 months is 125,126 and the stock's 52-week low/high is $0.10/$0.74995.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

The future of nuclear energy is becoming uncertain as the European Union looks for ways to decrease its dependence on oil and gas from Russia, which invaded Ukraine last month. Russia is the second-largest source of uranium around the globe despite the supply chain’s diversification, with countries such as Canada, Kazakhstan and Niger contributing substantial amounts of uranium. Currently, the domestic production of uranium in the EU is still low, with uranium being supplied from foreign sources making up more than 90% of total consumption. Russia, which has the biggest enrichment capacity globally, is also a major provider of enriched uranium. China has the second-biggest enrichment capacity across the globe. For the U.S. to become energy self-sufficient, it needs to incentivize investment into domestic enrichment facilities so that the uranium mined by stateside companies such as Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) doesn’t have to be shipped abroad for processing.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Thursday’s trading session at $10.17, up 2.6236%, on 5,184,417 volume. The average volume for the last 3 months is 5.169M and the stock's 52-week low/high is $4.32/$11.39.

Recent News

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF)

The QualityStocks Daily Newsletter would like to spotlight Mydecine Innovations Group Inc. (MYCOF).

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has received conditional approval from the Institutional Review Board ("IRB") for its planned multisite phase 2b smoking cessation trial. According to the announcement, Johns Hopkins University will serve as the lead investigational site for the study. The company anticipates submitting its IND application in the second quarter, with hopes that the study will begin shortly thereafter. Calling the approval a “significant milestone,” the company noted that its mission is to provide safer, more effective solutions to address nicotine dependence and other harmful addictions and this approval is one step closer to achieving that goal. “We are beyond excited to share the news of our conditional IRB approval for our Phase 2b clinical trial,” said Mydecine Innovations CEO Josh Bartch in the press release. “Upon the near-term clearance of our IND application, which is wholly owned by Mydecine, we will be the first commercial IND approved utilizing psilocybin for the indication of smoking cessation, and one of a small number of organizations with a commercial FDA IND approval, alongside COMPASS Pathways, MindMed and Usona, for a Phase 2 or later stage study assessing a psychedelic compound for any indication. We have a strong patent and regulatory strategy to support this initiative as well as further subsequent approvals.” To view the full press release, visit https://ibn.fm/Bkk5M

Mydecine Innovations Group Inc. (NEO: MYCO) (NASDAQ: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health disorders and addiction. Founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovations in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other mental health disorders.

Mydecine’s business model combines clinical trials and data outcome, technology and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine aims to responsibly fast-track the development of new medicines across its platforms, ultimately changing the way we treat mental health disorders. The company seeks to bridge the gap between the needs of patients and what the mental health care system currently provides.

Mydecine Innovations Group is headquartered in Denver with international offices in Canada and Europe.

Research and Technology

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of Mydecine’s research strategy. The company uses molecules found in nature as building blocks to create improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products and synthetics, including enhanced safety, efficacy, stability and dosing, as well as reduced side effects.

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients, along with improved management of dosage and drug behavior for clinicians. Mydecine believes the multibillion-dollar market for mental health and addiction disorder medicines will soon be disrupted amid a resurgence of the study into psychedelics and data showing the immense benefits of these forms of medicine.

The company currently has four lead drug candidates which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid PTSD, substance abuse and smoking cessation.

Mindleap Health is a wholly owned subsidiary of Mydecine. The Mindleap platform is a virtual community that aims to foster the conscious and responsible adoption of psychedelic medicine into inner wellness. Users access the platform through the Mindleap app. Mindleap provides users with inner wellness resources to assist them in their daily mental-health journeys. The platform also seeks to support the conscious and trustworthy adoption of psychedelics into a widely accepted approach to mental health and inner wellness.

Market Outlook

The global smoking cessation market is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9 percent from 2018 to 2026. The market for psychedelic therapeutics is in its very early stages. Estimates of current market value and forecasts of expected value in future years are all over the map. Market forecasts range from $6.5 billion by 2030 with a CAGR of 15 percent, to more than $69 billion as soon as 2025, at a CAGR of 8.2 percent. What is clear is that interest in psychedelic therapeutic drugs is expanding rapidly.

Management Team

Joshua Bartch is Chief Executive Officer and Chairman of Mydecine Innovations Group. He is an experienced entrepreneur who co-founded AudioTranscriptionist.com and founded Denver-based dispensary Doctors Orders in 2009. He also founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded Cannabase.io, the USA’s most significant and sophisticated legal cannabis wholesale platform.

Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is the Chief Medical Officer of Mydecine. He was formerly Chief of Psychiatry for the Canadian Armed Forces, retiring in 2021 with the rank of colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon and spent his final 20 years of service as a psychiatrist. He maintains academic appointments at Dalhousie University and The University of Ottawa. He is the inaugural CF Brigadier Jonathan C. Meakins CBE, RCMAC, Chair in Military Mental Health at the Royal Ottawa Hospital.

Robert Roscow is Chief Scientific Officer of Mydecine. As a geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. His innovations were applied at Canopy Growth and ebbu, where he ran those companies’ genetics divisions. He has leveraged his expertise to maximize industrial production of cannabinoids in a pharmacological context, resulting in multiple patent filings.

Damon Michaels is Chief Operating Officer of Mydecine. He previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as GM for ebbu, the leading multi-platform cannabinoid research and technology firm based in Colorado. He has held leading roles with multiple large brands throughout the cannabis vertical. He also developed a national snowboard brand.

Mydecine Innovations Group Inc. (MYCOF), closed Thursday’s trading session at $0.078, off by 2.378%, on 1,245,505 volume. The average volume for the last 3 months is 1.246M and the stock's 52-week low/high is $0.01/$2.20.

Recent News

Cannabis Strategic Ventures Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures Inc. (NUGS).

Cannabis has been one of the fastest-growing industries in the country for the past couple of years bringing in billions of dollars in sales and tax revenue. Over the pandemic, cannabis sellers saw month-over-month sales records while other sectors stagnated. Over the course of 2021, states with legal marijuana markets generated more than $3 billion in tax revenue from cannabis sales. A Marijuana Policy Project report shows that this is a slight improvement over the $2.7 billion states collected in 2020. All these discussions about how best to utilize the taxes generated from the marijuana industry show that licensed companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) are making a vital contribution to the communities in which they operate.

Cannabis Strategic Ventures Inc. (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator. The company is based in Los Angeles, with a 6-acre cannabis farm in Northern California called NUGS Farm North. The company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration.

Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the City of Los Angeles and the State of California, and it is now working toward taking operational control of each license. The company also recently announced the upcoming grand opening of its cannabis dispensary, MDRN Tree. Following that launch, Cannabis Strategic Ventures intends to deploy another of its new licenses to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. The facility will have up to 1,200 grow lights and is anticipated to yield 5.75 harvests per year, bringing it to a total production capacity of over 15,000 pounds of cannabis flower annually.

Brand Portfolio

The company owns multiple brands under the Cannabis Strategic Ventures umbrella. The firm’s NUGS brand provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands.

The NUGS Farm North brand operates as a six-and-a-half-acre cannabis cultivation property located in northern California. The company believes that the key to success in its business is consistent quality and reliable supply to fit growing consumer demand. Cannabis Strategic Ventures addressed these consumer needs by building NUGS Farm North. At NUGS Farm North, the company’s process is customized, and its product is consistent. Located in the heart of an agricultural mecca for globally distributed produce, NUGS Farm North finds power in its product, not in its size. Decades of agricultural experience and a dedication to consistency ensure quality cannabis.

MDRN Tree is Cannabis Strategic Ventures’ customer-facing dispensary brand. MDRN Tree will open its first Los Angeles location sometime in the fall of 2021. MDRN Tree will be the company’s factory retail store – a direct interface with the end-market community – where Cannabis Strategic Ventures plans on showcasing the cannabis flower produced at its NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability.

Market Outlook

The demand for legal marijuana is expected to surge due to ongoing changes in U.S. state government policies toward cannabis. In addition, the number of indications for which medical marijuana is prescribed continues to increase steadily. These factors are expected to rapidly boost legal sales of cannabis products, opening new revenue channels for producers and retailers. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will only present more high growth opportunities for this market.

According to a report from Grand View Research, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a compound annual growth rate of 26.7 percent from 2021 to 2028. That CAGR would put the market value at roughly $30 billion as soon as 2025.

According to the report, “One of the major factors fueling market growth is the expanding demand for legal marijuana owing to the growing number of legal cannabis countries. (Due) to recent legalizations in different countries, the use of medical marijuana for various ailments is gaining momentum worldwide. Patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders are administered medical marijuana. The demand for cannabis oil is increasing rapidly, especially among countries with legalized medical marijuana.”

Management Team

Simon Yu is CEO, President, CFO and Secretary of Cannabis Strategic Ventures. He is also a co-founder, former COO and board member of Clubhouse Media Group Inc., a publicly traded social media company. Mr. Yu holds an MBA from the University of Southern California.

Cannabis Strategic Ventures Inc. (NUGS), closed Thursday’s trading session at $0.0225, up 25%, on 4,347,495 volume. The average volume for the last 3 months is 4.347M and the stock's 52-week low/high is $0.014794/$0.14.

Recent News

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

The QualityStocks Daily Newsletter would like to spotlight Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF).

Eat Well Group (CSE: EWG) (OTC: EWGFF) has announced that organic plant-based baby food from its majority-owned Amara Organice Foods is now available in Sobeys and IGA stores in Canada. Amara is one of the fastest-growing baby food brands in America. In business for more than a century, Sobeys is one of only two national grocery retailers in Canada and has an estimated 1,500 stores across the 10 Canadian provinces; those locations include Sobeys, Safeway, IGA, Foodland, FreshCo, Thrifty Foods and Lawtons Drugs along with more than 350 retail fuel locations. These new locations strengthen the company’s already-strong footprint in the country, with its products available in Walmart Canada, Whole Foods, Sprouts Farmer’s Market, HEB, and Loblaws locations. “Amara adds premier distribution points in both Sobeys and IGA stores, some of North America’s most well-known and established grocery retailers,” said Eat Well Group director and CEO Marc Aneed in the press release. “The demand for plant-based infant nutrition continues to be strong as we accelerate growth across Eat Well Group’s CPG sector. We congratulate the Amara team for ongoing success.” To view the full press release, visit https://ibn.fm/Uoslr

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022.

Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company.

The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products.

Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada.

Portfolio

On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein.

Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today.

Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch.

Market Outlook

According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research.

Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply.

Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition.

The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue.

Management Team

Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales.

Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing.

Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management.

Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses.

Strategic Advisory Board

HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth.

Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter.

Eat Well Investment Group Inc. (OTC: EWGFF), closed Thursday’s trading session at $0.337, up 3.2159%, on 18,975 volume. The average volume for the last 3 months is 5,475 and the stock's 52-week low/high is $0.308/$1.00.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, will be participating in this month’s Maxim Virtual Growth Conference. CPTN CEO Dr. Jun Pei will be participating in a panel discussion during the one-day conference, which is scheduled for March 29, 2022. Titled “Taking the Wheel: Making Cars and Mobility Smarter,” the panel will feature other automotive leaders as well and is slated to begin at 11 a.m. ET. Pei will also be available for one-on-one meetings throughout the event. To view the panel discussion, visit https://ibn.fm/fXYA5. To view the full press release, visit https://ibn.fm/2ItqW.

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Thursday’s trading session at $4.05, up 1.25%, on 427,994 volume. The average volume for the last 3 months is 425,496 and the stock's 52-week low/high is $3.62/$80.16.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.